Source: Virtual Congress 2021 – COVID-19 and management of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
R. Chen (Shanghai, China), . Lu (Shanghai, China), M. Zhou (Shanghai, China), Y. Guo (Shanghai, China). Absolute neutrophil count in peripheral blood predict prognosis in lung cancer patients treated with anlotinib. 3858

Member's Comments

No comment yet.

Related content which might interest you: Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study> Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Preoperative cell counts of white blood cell, neutrophil, lymphocyte and neutrophil/lymphocyte ratio as a predictive parameter of survival rate after complete resection for non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Prognostic significance of blood coagulation tests in lung cancer Source: Eur Respir J 2001; 17: 667-673 Year: 2001 Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Peripheral blood leukocyte telomere length is associated with survival of sepsis patients Source: Eur Respir J, 55 (1) 1901044; 10.1183/13993003.01044-2019 Year: 2020 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up. Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses? Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017